BioSpace News Archive

Collaboration between device manufacturers, clinicians, technology developers, and researchers in additive manufacturing (AM) will be on full display at the Fort Worth Convention Center during SME’s RAPID + TCT event, April 23-26. RAPID + TCT, now in its 28th year, is a leading forum for ideas and showcase of technology in the still growing and ever-evolving world of 3D printing (3DP).

Douglas Russell joins LHS as Senior Vice President & General Manager

Total revenues were $19.5 million and net profit was $8.2 million for the three months ended December 31, 2017 as compared to total revenues of $3.5 million and net loss of $8.8 million for the three months ended December 31, 2016.

Cash and investments in marketable securities at December 31, 2017 were $353.2 million as compared to $389.1 million at December 31, 2016.

Total year 2017 OMIDRIA revenues were $64.8 million, a 56.4 percent increase over 2016.

TRULANCE® U.S. net sales were $9.4 million in the fourth quarter, totaling $16.8 million for 2017.

Achieve Life Sciences, Inc. highlighted recent accomplishments and announced fourth quarter and year-end 2017 financial results.

Perrigo Company plc announced results for the fourth quarter and calendar year ended December 31, 2017.

Aytu BioScience, Inc. announced the pricing of an underwritten public offering with expected total gross proceeds of $12,000,000, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

Quarterly GAAP revenues of $77.0 million and net loss attributable to Intrexon of $27.3 million including non-cash charges of $41.5 million